{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:53:57Z","timestamp":1785542037288,"version":"3.56.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejphar.2024.176880","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T01:22:59Z","timestamp":1723252979000},"page":"176880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays"],"prefix":"10.1016","volume":"981","author":[{"given":"Chiara","family":"Sturaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-202X","authenticated-orcid":false,"given":"Chiara","family":"Ruzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Argentieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Frezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Marzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5842-105X","authenticated-orcid":false,"given":"Barbara","family":"Bettegazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-9550","authenticated-orcid":false,"given":"Davide","family":"Malfacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolamo","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176880_bib1","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/dom.13020","article-title":"Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease","volume":"19","author":"Abegg","year":"2017","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2024.176880_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2019.09.006","article-title":"Ghrelin signaling: GOAT and GHS-r1a take a LEAP in complexity","volume":"31","author":"Abizaid","year":"2020","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2024.176880_bib3","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1021\/jm0705051","article-title":"Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists","volume":"50","author":"Altenbach","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1124\/mol.118.112573","article-title":"Equilibrium assays are required to accurately characterize the activity profiles of drugs modulating gq-protein-coupled receptors","volume":"94","author":"Bdioui","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/nure.12045","article-title":"Ghrelin, neuropeptide Y, and other feeding-regulatory peptides active in the hippocampus: role in learning and memory","volume":"71","author":"Beck","year":"2013","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejphar.2024.176880_bib6","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm0001727","article-title":"Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a","volume":"43","author":"Bednarek","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107234","article-title":"Differential impact of a ghrelin receptor antagonist or inverse agonist in the electrical kindling model of epilepsy","volume":"197","author":"Beheshti","year":"2023","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2024.176880_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/ml400473x","article-title":"Discovery of PF-5190457, a potent, selective, and orally bioavailable ghrelin receptor inverse agonist clinical candidate","volume":"5","author":"Bhattacharya","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2024.176880_bib9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jcsm.12439","article-title":"Appetite and food intake results from phase I studies of anamorelin","volume":"10","author":"Blum","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.176880_bib10","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1152\/ajpregu.00044.2016","article-title":"The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats","volume":"311","author":"Borner","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2024.176880_bib11","series-title":"Tetrahydrospiro-beta-carboline-1,3 \u2019-pyrrolidine Derivatives and Their Use in Ghsr-Related Disorders","author":"Brandt","year":"2005"},{"key":"10.1016\/j.ejphar.2024.176880_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010053","article-title":"Targeting the ghrelin receptor as a novel therapeutic option for epilepsy","volume":"10","author":"Buckinx","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2024.176880_bib13","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1111\/ene.14992","article-title":"Translational potential of the ghrelin receptor agonist macimorelin for seizure suppression in pharmacoresistant epilepsy","volume":"28","author":"Buckinx","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2024.176880_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102480","article-title":"Differential effects of a full and biased ghrelin receptor agonist in a mouse kindling model","volume":"20","author":"Buckinx","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176880_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.711500","article-title":"New developments in prokinetic therapy for gastric motility disorders","volume":"12","author":"Camilleri","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib16","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3390\/ijms22052397","article-title":"Cannabinoid-induced conditioned place preference, intravenous self-administration, and behavioral stimulation influenced by ghrelin receptor antagonism in rats","volume":"22","author":"Charalambous","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176880_bib17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2010.00863.x","article-title":"Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays","volume":"161","author":"Charlton","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40262-020-00942-7","article-title":"A population pharmacokinetic analysis of PF-5190457, a novel ghrelin receptor inverse agonist in healthy volunteers and in heavy alcohol drinkers","volume":"60","author":"Cobbina","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2024.176880_bib19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/ijms18040798","article-title":"Therapeutic potential of targeting the ghrelin pathway","volume":"18","author":"Colld\u00e9n","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176880_bib20","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1111\/epi.13463","article-title":"Anticonvulsant effect of a ghrelin receptor agonist in 6Hz corneally kindled mice","volume":"57","author":"Coppens","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2024.176880_bib21","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"Romana 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2024.176880_bib22","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1021\/acs.jmedchem.8b00794","article-title":"Rational design, synthesis, and pharmacological characterization of novel ghrelin receptor inverse agonists as potential treatment against obesity-related metabolic diseases","volume":"61","author":"Daina","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib23","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1074\/jbc.M111.288324","article-title":"High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs","volume":"287","author":"Damian","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bcp.13127","article-title":"Pharmacokinetics and pharmacodynamics of PF-05190457: the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects","volume":"83","author":"Denney","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134367","article-title":"Role of mesolimbic ghrelin in the acquisition of cocaine reward","volume":"709","author":"Dunn","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2024.176880_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174039","article-title":"A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus accumbens shell in rats","volume":"899","author":"Edvardsson","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib27","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1210\/en.2007-0239","article-title":"Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss","volume":"148","author":"Esler","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2024.176880_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2018.07.004","article-title":"Pharmacological manipulation of the ghrelin system and alcohol hangover symptoms in heavy drinking individuals: is there a link?","volume":"172","author":"Farokhnia","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176880_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146851","article-title":"Effects of exogenous ghrelin administration and ghrelin receptor blockade, in combination with alcohol, on peripheral inflammatory markers in heavy-drinking individuals: results from two human laboratory studies","volume":"1740","author":"Farokhnia","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.176880_bib30","series-title":"Asymmetric Ureas and Medical Uses Thereof (WO2012113103A1)","author":"Garcia Rubio","year":"2012"},{"key":"10.1016\/j.ejphar.2024.176880_bib31","series-title":"Fumarate Salt Of(r)-3-(1-(2,3-Dichloro-4-(pyrazin-2-Yl)phenyl)-2,2,2-Trifluoroethyl)-1-Methyl-1-(1-Methylpiperidin-4-Yl)urea, Methods of Preparation, and Uses Thereof","author":"Garcia Rubio","year":"2019"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176880_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2017.10.016","article-title":"LEAP2 is an endogenous antagonist of the ghrelin receptor","volume":"27","author":"Ge","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2024.176880_bib33","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/acs.jmedchem.1c02191","article-title":"Advances in the development of nonpeptide small molecules targeting ghrelin receptor","volume":"65","author":"Giorgioni","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib34","series-title":"Benzenesulfonyl-asymmetric Ureas and Medical Uses Thereof (WO2017162390)","author":"Giuliano","year":"2017"},{"key":"10.1016\/j.ejphar.2024.176880_bib35","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/acer.12499","article-title":"The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL\/6J mice","volume":"38","author":"Gomez","year":"2014","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2024.176880_bib36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.bjp.0702415","article-title":"Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C","volume":"126","author":"Grimberg","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4939-2336-6_14","article-title":"Label-free biosensor assays in GPCR screening","volume":"1272","author":"Grundmann","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2024.176880_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-328X(97)00071-5","article-title":"Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues","volume":"48","author":"Guan","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176880_bib39","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1073\/pnas.0800708105","article-title":"Ghrelin octanoylation mediated by an orphan lipid transferase","volume":"105","author":"Gutierrez","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2024.176880_bib40","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1021\/acs.jmedchem.9b02122","article-title":"Development of nonpeptidic inverse agonists of the ghrelin receptor (GHSR) based on the 1,2,4-triazole scaffold","volume":"63","author":"Haj Salah","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib41","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2024.176880_bib42","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3390\/ijms19102925","article-title":"Ghrelin receptor antagonism of methamphetamine-induced conditioned place preference and intravenous self-administration in rats","volume":"19","author":"Havlickova","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176880_bib43","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1210\/me.2005-0059","article-title":"Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling","volume":"19","author":"Holst","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.176880_bib44","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/me.2003-0069","article-title":"High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist","volume":"17","author":"Holst","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.176880_bib45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1006\/bbrc.2000.4039","article-title":"Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue","volume":"279","author":"Hosoda","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.176880_bib46","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.273.5277.974","article-title":"A receptor in pituitary and hypothalamus that functions in growth hormone release","volume":"273","author":"Howard","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2024.176880_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.physbeh.2016.03.039","article-title":"Ghrelin: a link between memory and ingestive behavior","volume":"162","author":"Hsu","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2024.176880_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171050","article-title":"Desacyl-ghrelin, not just an inactive form of ghrelin? A review of current knowledge on the biological actions of desacyl-ghrelin","volume":"167","author":"Iwakura","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2024.176880_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100945","article-title":"Ghrelin in Alzheimer's disease: pathologic roles and therapeutic implications","volume":"55","author":"Jeon","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2024.176880_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuint.2017.09.013","article-title":"Ghrelin receptor antagonism of morphine-induced conditioned place preference and behavioral and accumbens dopaminergic sensitization in rats","volume":"110","author":"Jerabek","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2024.176880_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2011.01.010","article-title":"Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice","volume":"117","author":"Jerlhag","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2024.176880_bib52","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.expneurol.2008.05.006","article-title":"Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra","volume":"212","author":"Jiang","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176880_bib53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2826.1999.00330.x","article-title":"Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats","volume":"11","author":"Kamegai","year":"1999","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2024.176880_bib54","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/nmo.12459","article-title":"New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease","volume":"26","author":"Karasawa","year":"2014","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2024.176880_bib55","series-title":"A Pharmacology Primer","author":"Kenakin","year":"2018"},{"key":"10.1016\/j.ejphar.2024.176880_bib56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176880_bib57","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bph.13439","article-title":"Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo","volume":"173","author":"Kong","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biopsycho.2016.12.012","article-title":"The impact of the appetite-regulating, orexigenic peptide ghrelin on alcohol use disorders: a systematic review of preclinical and clinical data","volume":"131","author":"Koopmann","year":"2018","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.ejphar.2024.176880_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107788","article-title":"Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers","volume":"170","author":"Lee","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176880_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41380-018-0064-y","article-title":"The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study","volume":"25","author":"Lee","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2024.176880_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/adt.2014.590","article-title":"A comparison of assay performance between the calcium mobilization and the dynamic mass redistribution technologies for the human urotensin receptor","volume":"12","author":"Lee","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejphar.2024.176880_bib62","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1074\/jbc.M006359200","article-title":"Constitutive signaling by Kaposi's sarcoma-associated herpesvirus G-protein-coupled receptor desensitizes calcium mobilization by other receptors","volume":"276","author":"Lupu-Meiri","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib63","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn.2139","article-title":"The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress","volume":"11","author":"Lutter","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176880_bib64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1006\/bbrc.2000.3568","article-title":"Ghrelin stimulates gastric acid secretion and motility in rats","volume":"276","author":"Masuda","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.176880_bib65","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1074\/jbc.270.3.1041","article-title":"Truncation of the thyrotropin-releasing hormone receptor carboxyl tail causes constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells","volume":"270","author":"Matus-Leibovitch","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib66","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1021\/jm500610n","article-title":"Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists","volume":"57","author":"McCoull","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib67","doi-asserted-by":"crossref","first-page":"E10255","DOI":"10.1073\/pnas.1804003115","article-title":"Translating biased signaling in the ghrelin receptor system into differential in vivo functions","volume":"115","author":"Mende","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2024.176880_bib68","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/mp.2013.135","article-title":"A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear","volume":"19","author":"Meyer","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2024.176880_bib69","first-page":"13","article-title":"Multiple beneficial effects of ghrelin agonist, HM01 on homeostasis alterations in 6-hydroxydopamine model of Parkinson's disease in male rats. Front. Integr","volume":"13","author":"Minalyan","year":"2019","journal-title":"Neurosciences"},{"key":"10.1016\/j.ejphar.2024.176880_bib70","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/cancers12071942","article-title":"Supplementary oral anamorelin mitigates anorexia and skeletal muscle atrophy induced by gemcitabine plus cisplatin systemic chemotherapy in a mouse model","volume":"12","author":"Miyake","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176880_bib71","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/acs.jmedchem.8b01644","article-title":"N-terminal liver-expressed antimicrobial peptide 2 (LEAP2) region exhibits inverse agonist activity toward the ghrelin receptor","volume":"62","author":"M'Kadmi","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib72","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1021\/jm0704550","article-title":"Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations","volume":"50","author":"Moulin","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13539-010-0012-4","article-title":"Ghrelin and its potential in the treatment of eating\/wasting disorders and cachexia","volume":"1","author":"M\u00fcller","year":"2010","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.176880_bib74","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00520-013-1800-0","article-title":"Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model","volume":"21","author":"Northrup","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejphar.2024.176880_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/JEP.S249747","article-title":"Attenuation of visceral and somatic nociception by ghrelin mimetics","volume":"12","author":"N Mohammadi","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib76","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00213-014-3640-0","article-title":"The role of ghrelin in addiction: a review","volume":"231","author":"Panagopoulos","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2024.176880_bib77","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1172\/JCI25303","article-title":"Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature","volume":"116","author":"Pantel","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.176880_bib78","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejphar.2010.10.042","article-title":"Pharmacological characterization of the ghrelin receptor antagonist, GSK1614343 in rat RC-4B\/C cells natively expressing GHS type 1a receptors","volume":"650","author":"Perdon\u00e0","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13224","article-title":"Toward a consensus nomenclature for ghrelin, its non-acylated form, liver expressed antimicrobial peptide 2 and growth hormone secretagogue receptor","volume":"35","author":"Perell\u00f3","year":"2023","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2024.176880_bib80","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1210\/en.2008-1638","article-title":"In vivo characterization of high Basal signaling from the ghrelin receptor","volume":"150","author":"Petersen","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2024.176880_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.176880_bib82","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s13311-012-0125-x","article-title":"Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents","volume":"9","author":"Portelli","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2024.176880_bib83","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41467-022-27975-9","article-title":"Molecular mechanism of agonism and inverse agonism in ghrelin receptor","volume":"13","author":"Qin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2024.176880_bib84","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1096\/fj.201800655R","article-title":"Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists","volume":"33","author":"Ramirez","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2024.176880_bib85","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1177\/10781552231189864","article-title":"The effect of anamorelin (ONO-7643) on cachexia in cancer patients: systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Rezaei","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ejphar.2024.176880_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109643","article-title":"Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice","volume":"238","author":"Richardson","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176880_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1267414","article-title":"In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay","volume":"14","author":"Ruzza","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176880_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.445","article-title":"Pharmacological profile of the neuropeptide S receptor: dynamic mass redistribution studies","volume":"6","author":"Ruzza","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejphar.2024.176880_bib89","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nbt.1671","article-title":"Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements","volume":"28","author":"Schr\u00f6der","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2024.176880_bib90","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1038\/s41467-020-17554-1","article-title":"Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode","volume":"11","author":"Shiimura","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2024.176880_bib91","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuropharm.2006.04.009","article-title":"Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system","volume":"51","author":"Sibilia","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176880_bib92","doi-asserted-by":"crossref","first-page":"20845","DOI":"10.1074\/jbc.M110.173237","article-title":"Unique interaction pattern for a functionally biased ghrelin receptor agonist","volume":"286","author":"Sivertsen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12845","article-title":"Ghrelin receptor antagonism of fentanyl-induced conditioned place preference, intravenous self-administration, and dopamine release in the nucleus accumbens in rats","volume":"25","author":"Sustkova-Fiserova","year":"2020","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2024.176880_bib94","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.bmc.2015.05.047","article-title":"Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model","volume":"23","author":"Takahashi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176880_bib95","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2024.176880_bib96","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/ijms18050986","article-title":"Oral treatment with the ghrelin receptor agonist HM01 attenuates cachexia in mice bearing colon-26 (C26) tumors","volume":"18","author":"Villars","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176880_bib97","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejphar.2024.176880_bib98","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2008.01.017","article-title":"Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone","volume":"132","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.176880_bib99","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00520-021-06463-8","article-title":"Anamorelin combined with physical activity, and nutritional counseling for cancer-related fatigue: a preliminary study","volume":"30","author":"Yennurajalingam","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejphar.2024.176880_bib100","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1073\/pnas.1002271107","article-title":"Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice","volume":"107","author":"Zhao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2024.176880_bib101","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cne.20823","article-title":"Expression of ghrelin receptor mRNA in the rat and the mouse brain","volume":"494","author":"Zigman","year":"2006","journal-title":"J. Comp. Neurol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924005697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924005697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T16:14:33Z","timestamp":1729872873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924005697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":101,"alternative-id":["S0014299924005697"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176880","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176880"}}